SCHEDULE 13G/A 0001140361-24-022952 0001232258 XXXXXXXX LIVE 2 Common Stock, par value $0.0001 per share 12/31/2024 0001808898 Benitec Biopharma Inc. 08205P209 3940 Trust Way Hayward CA 94545 Rule 13d-1(c) HBM Healthcare Investments (Cayman) Ltd. E9 1041669.00 0.00 1041669.00 0.00 1041669.00 N 4.5 CO Voting and investment power over the shares held by HBM Healthcare Investments (Cayman) Ltd. is exercised by the board of directors of HBM Healthcare Investments (Cayman) Ltd. (the "Board"). The Board consists of Jean-Marc LeSieur, Richard H. Coles, Sophia Harris, Dr. Andreas Wicki, Mark Kronenfeld, M.D., and Richard Paul Woodhouse, none of whom has individual voting or investment power with respect to the shares. Benitec Biopharma Inc. 3940 Trust Way, Hayward, CA, 94545 HBM Healthcare Investments (Cayman) Ltd. (the "Reporting Person") Governors Square, 23 Lime Tree Bay Avenue, PO Box 30852, Grand Cayman, KY1-1204, Cayman Islands Cayman Islands, British West Indies Y As of December 31, 2024, the Reporting Person may be deemed the beneficial owner of 1,041,669 shares of Common Stock, which represents approximately 4.5% of the shares of Common Stock outstanding. The percentage set forth herein is calculated based on 23,216,425 shares of Common Stock outstanding as of November 12, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2024. 4.5 1,041,669 0 1,041,669 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. HBM Healthcare Investments (Cayman) Ltd. /s/ Jean-Marc LeSieur 02/13/2025